HDACs/mTOR Inhibitor 1
STAT5-IN-2
Onvatilimab
AFM-30a hydrochloride
HDAC-IN-40
T-448
Avicularin
MC4355
ZL0454
BOLD-100
MAP4K4-IN-3
c-Kit-IN-5-1
BI-853520
2'-O-MOE-rC
2'-O,4'-C-Methyleneguanosine
N1-Methylpseudouridine-5′-triphosphate trisodium
2'-Deoxy-5'-O-DMT-2'-fluorouridine
Eugenol-d3
YM-341619
EGFR-IN-17
Myelin Basic Protein TFA
Vorapaxar sulfate
NRX-252114
BTX161
Solanidine
Fustin
Atraric acid
(±)-U-50488 hydrate hydrochloride
(±)-α-Tocopherol nicotinate
Etokimab
(Rac)-PF-184 hydrate
(±)-Cannabichromene
15(S)-HETE-d8 ethyl ester
2-Hydroxyemodin
Orotidine 5′-monophosphate trisodium
RIPGBM
Rapanone
Benastatin A
Phenethyl isothiocyanate
TJ191
SRT 1460
SW-100
Bomedemstat
FHD-286
Procainamide
PARP-1-IN-2
ZL0590
Miravirsen
Tiopronin-d3
Moracin O
Senaparib
Reuterin
AZD 2716
Gunagratinib
PF-06456384 trihydrochloride
DA-JC4
FGFR4-IN-5
SRX3207
HS271
Taletrectinib
